Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter W Johnson

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Blood Advances|February 7, 2019
Genome-wide promoter methylation of hairy cell leukemiaAlberto J Arribas, Andrea Rinaldi, Giorgia Chiodin, et al.
Blood|June 16, 2016
Surface IgM expression and function are associated with clinical behavior, genetic abnormalities, and DNA methylation in CLLAnnalisa D'Avola, Samantha Drennan, Ian Tracy, et al.
Hematological Oncology|November 23, 2011
Hepatitis C virus and GBV-C virus prevalence among patients with B-cell lymphoma in different European regions: a case-control study of the International Extranodal Lymphoma Study GroupSabrina Nicolosi Guidicelli, Armando Lopez-Guillermo, Umberto Falcone, et al.
Blood|May 4, 2018
Metabolic heterogeneity on baseline 18FDG-PET/CT scan is a predictor of outcome in primary mediastinal B-cell lymphomaLuca Ceriani, Lisa Milan, Maurizio Martelli, et al.
Haematologica|July 16, 2016
European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphomaPier Luigi Zinzani, Lionel Karlin, John Radford, et al.
Blood|January 10, 2016
PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma studySally F Barrington, Amy A Kirkwood, Antonella Franceschetto, et al.
The Oncologist|August 14, 2015
Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue of the Salivary Glands: A Multicenter, International Experience of 248 Patients (IELSG 41)Amie E Jackson, Michael Mian, Christina Kalpadakis, et al.
The Oncologist|February 5, 2014
A catalyst for change: the European cancer Patient's Bill of RightsMark Lawler, Thierry Le Chevalier, Martin J Murphy, et al.
Leukemia|May 13, 2022
Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trialAndrés J M Ferreri, Kate Cwynarski, Elisa Pulczynski, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Blood Advances|February 7, 2019
Genome-wide promoter methylation of hairy cell leukemiaAlberto J Arribas, Andrea Rinaldi, Giorgia Chiodin, et al.
Blood|June 16, 2016
Surface IgM expression and function are associated with clinical behavior, genetic abnormalities, and DNA methylation in CLLAnnalisa D'Avola, Samantha Drennan, Ian Tracy, et al.
Hematological Oncology|November 23, 2011
Hepatitis C virus and GBV-C virus prevalence among patients with B-cell lymphoma in different European regions: a case-control study of the International Extranodal Lymphoma Study GroupSabrina Nicolosi Guidicelli, Armando Lopez-Guillermo, Umberto Falcone, et al.
Blood|May 4, 2018
Metabolic heterogeneity on baseline 18FDG-PET/CT scan is a predictor of outcome in primary mediastinal B-cell lymphomaLuca Ceriani, Lisa Milan, Maurizio Martelli, et al.
Haematologica|July 16, 2016
European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphomaPier Luigi Zinzani, Lionel Karlin, John Radford, et al.
Blood|January 10, 2016
PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma studySally F Barrington, Amy A Kirkwood, Antonella Franceschetto, et al.
The Oncologist|August 14, 2015
Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue of the Salivary Glands: A Multicenter, International Experience of 248 Patients (IELSG 41)Amie E Jackson, Michael Mian, Christina Kalpadakis, et al.
The Oncologist|February 5, 2014
A catalyst for change: the European cancer Patient's Bill of RightsMark Lawler, Thierry Le Chevalier, Martin J Murphy, et al.
Leukemia|May 13, 2022
Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trialAndrés J M Ferreri, Kate Cwynarski, Elisa Pulczynski, et al.
Pageof 9